secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vyome Holdings, Inc (HIND)
CIK:        0001427570
Form:       8-K
Filed at:   2025-05-30T23:59:59+00:00
Accession:  0001104659-25-054876
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ReShape Lifesciences enters $9.7M at-the-market equity distribution agreement with Maxim Group
--------------------------------------------------------------------------------

- Agreement allows sale of up to $9.7M of common stock via ATM offering; effective May 30, 2025.
- Maxim receives 3.0% commission on gross proceeds plus up to $50K legal fee reimbursement and $3K per due diligence session.
- Shares sold under existing effective S-3 shelf registration (File No. 333-287168).
- Company has no obligation to sell; offering ends upon sale of $9.7M or termination by either party.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427570/000110465925054876/0001104659-25-054876-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427570/000110465925054876/tm2516583d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-054876

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer